About
Small molecule for neurological disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalAustralia
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
529
By Phase
PHASE4: 1NA: 2PHASE2: 2PHASE3: 1
By Status
COMPLETED: 5UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05002179Collaborator
Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections
PHASE4Completed
122 participants
Started: Nov 20, 2020 · Completed: May 29, 2021
NCT03885999Lead Sponsor
Studies in Patients With Low Anterior Resection Syndrome (LARS)
NACompleted
12 participants
Started: May 29, 2019 · Completed: Mar 1, 2020
NCT03317938Lead Sponsor
Studies in Patients With Defecatory Disorders
NAUnknown
236 participants
Started: Aug 14, 2017 · Completed: Dec 31, 2023
NCT00656812Collaborator
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
PHASE2Completed
40 participants
Started: May 31, 2008 · Completed: Sep 30, 2011
NCT00349453Lead Sponsor
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
PHASE2Completed
24 participants
Started: Mar 31, 2005 · Completed: May 31, 2011
Locations (1)
Headquarters
Sydney, Australia
Map
Loading map...